Why We Invested in Kirontech

It is easy to file Kirontech under ‘medtech’, but that undersells it. What they really do is turn raw medical data into knowledge and efficiency. Their platform reads claims and clinical data with graph-based machine learning that discovers the patterns of fraud, waste and abuse from within the data itself, rather than matching pre-written rules that fraudsters quickly learn to dodge.

We backed them because the defensibility sits in that combination — proprietary medical data, genuine clinical-domain expertise, and models that have to be explainable to survive in a regulated setting. You cannot clone this with a horizontal AI overlay. It is real domain depth, in a field where being right, and being able to show why, is the whole product.

It reaches straight into AI insurtech and the data layer beneath both. Healthcare only works if its insurance markets are efficient, and today they leak enormous sums to fraud, waste and error — money that should be paying for care. Kirontech attacks exactly that, with payment-integrity, health-outcomes and data-integrity modules that move payers from reactive audits to proactive intelligence. Updated FDA SaMD guidance and tougher EU MDR enforcement reward precisely this proprietary-data, explainable-model approach over thin AI wrappers, and ISO 27001 certification clears the bar for sensitive claims data. Healthcare is mission-critical by definition, so buyers won’t settle for a generic answer. That intolerance is the moat.

Fraud, waste and error leak out of every payer’s system in ways no rules engine will ever catch. Kirontech finds them by learning the patterns directly from your data, and it shows its working on every flag, so each one holds up under scrutiny and audit. Payers report returns on the order of seven to eight times — money recovered, care protected, and a claims operation that finally runs efficiently. If you are an insurer or a health payer, this is how your market becomes sustainable instead of slowly bleeding out.